GetTopicDetailResponse(id=d99b10012b4, topicName=Ipsen, introduction=Ipsen, content=null, image=null, comments=4, allHits=979, url=https://h5.medsci.cn/topic?id=10012, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=72372, tagList=[TagDto(tagId=72372, tagName=Ipsen)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2050131, encodeId=33e320501315a, content=<a href='/topic/show?id=d99b10012b4' target=_blank style='color:#2F92EE;'>#Ipsen#</a>, objectTitle=Ipsen在英國(guó)推出了新的自注射Somatuline，治療胃腸胰神經(jīng)內(nèi)分泌腫瘤, objectType=article, longId=177385, objectId=0ec61e738551, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ec61e738551, replyNumber=0, likeNumber=87, createdTime=2020-01-21, rootId=0, userName=soongzhihua, userId=7f52347, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ec61e738551, moduleTitle=Ipsen在英國(guó)推出了新的自注射Somatuline，治療胃腸胰神經(jīng)內(nèi)分泌腫瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0ec61e738551)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2050130, encodeId=5d3220501303d, content=<a href='/topic/show?id=d99b10012b4' target=_blank style='color:#2F92EE;'>#Ipsen#</a>, objectTitle=Ipsen將以13億美元的收購(gòu)罕見病公司Clementia, objectType=article, longId=161114, objectId=696316111419, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=696316111419, replyNumber=0, likeNumber=79, createdTime=2019-03-30, rootId=0, userName=soongzhihua, userId=7f52347, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=696316111419, moduleTitle=Ipsen將以13億美元的收購(gòu)罕見病公司Clementia, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=696316111419)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2050129, encodeId=baa0205012989, content=<a href='/topic/show?id=d99b10012b4' target=_blank style='color:#2F92EE;'>#Ipsen#</a>, objectTitle=Ipsen的Cometriq獲NICE資助, objectType=article, longId=133740, objectId=6ab3133e4093, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ab3133e4093, replyNumber=0, likeNumber=73, createdTime=2018-05-17, rootId=0, userName=soongzhihua, userId=7f52347, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ab3133e4093, moduleTitle=Ipsen的Cometriq獲NICE資助, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6ab3133e4093)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2050128, encodeId=ee32205012893, content=<a href='/topic/show?id=d99b10012b4' target=_blank style='color:#2F92EE;'>#Ipsen#</a>, objectTitle=IPSEN類癌綜合征腹瀉藥物Xermelo獲歐盟批準(zhǔn), objectType=article, longId=113653, objectId=88dc11365386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88dc11365386, replyNumber=0, likeNumber=84, createdTime=2018-01-01, rootId=0, userName=soongzhihua, userId=7f52347, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88dc11365386, moduleTitle=IPSEN類癌綜合征腹瀉藥物Xermelo獲歐盟批準(zhǔn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=88dc11365386)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
